Vijayakumar S - Search Results

1

Clinical trials involving vitamin D analogs in prostate cancer.

Vijayakumar S, Mehta RR, Boerner PS, Packianathan S, Mehta RG. Vijayakumar S, et al. Cancer J. 2005 Sep-Oct;11(5):362-73. doi: 10.1097/00130404-200509000-00002. Cancer J. 2005. PMID: 16259866 Review.

2

Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trial.

Chung TD, Park II, Ignacio L, Catchatourian R, Kopnick M, Davison E, Conrad G, Awan AM, Crawford D, Vijayakumar S. Chung TD, et al. Among authors: vijayakumar s. Int J Cancer. 2000 Oct 20;90(5):302-4. Int J Cancer. 2000. PMID: 11091355 Free article. No abstract available.

3

Designing a randomized phase I/II prostate cancer chemoprevention trial using 1alpha-hydroxy-24-ethyl-cholecalciferol, an analogue of vitamin D3.

Packianathan S, Mehta RG, Mehta RR, Hall WH, Boerner PS, Beckett LA, Vijayakumar S. Packianathan S, et al. Among authors: vijayakumar s. Cancer J. 2004 Nov-Dec;10(6):357-67. doi: 10.1097/00130404-200411000-00005. Cancer J. 2004. PMID: 15701267

4

A critical review of variables affecting the accuracy and false-negative rate of sentinel node biopsy procedures in early breast cancer.

Vijayakumar V, Boerner PS, Jani AB, Vijayakumar S. Vijayakumar V, et al. Among authors: vijayakumar s. Nucl Med Commun. 2005 May;26(5):395-405. doi: 10.1097/00006231-200505000-00002. Nucl Med Commun. 2005. PMID: 15838421 Review.

5

Recent developments in nuclear medicine in the management of bone metastases: a review and perspective.

Damerla V, Packianathan S, Boerner PS, Jani AB, Vijayakumar S, Vijayakumar V. Damerla V, et al. Among authors: vijayakumar s, vijayakumar v. Am J Clin Oncol. 2005 Oct;28(5):513-20. doi: 10.1097/01.coc.0000162425.55457.10. Am J Clin Oncol. 2005. PMID: 16199993 Review.

6

Clinical trials using chemopreventive vitamin D analogs in breast cancer.

Vijayakumar S, Boerner PS, Mehta RR, Packianathan S, Mehta RG, Das Gupta TK. Vijayakumar S, et al. Cancer J. 2006 Nov-Dec;12(6):445-50. doi: 10.1097/00130404-200611000-00001. Cancer J. 2006. PMID: 17207311 Review.

7

Introducing new technologies into the clinic.

Vijayakumar S, Narayan S, Yang CC, Boerner P, Jacob R, Mathai M, Harse R, Purdy J. Vijayakumar S, et al. Front Radiat Ther Oncol. 2007;40:180-192. doi: 10.1159/000106035. Front Radiat Ther Oncol. 2007. PMID: 17641509 Review.

8

Lack of Cetuximab induced skin toxicity in a previously irradiated field: case report and review of the literature.

Kanakamedala MR, Packianathan S, Vijayakumar S. Kanakamedala MR, et al. Among authors: vijayakumar s. Radiat Oncol. 2010 May 17;5:38. doi: 10.1186/1748-717X-5-38. Radiat Oncol. 2010. PMID: 20478052 Free PMC article.

9

A prolonged time interval between trauma and prophylactic radiation therapy significantly increases the risk of heterotopic ossification.

Mourad WF, Packianathan S, Shourbaji RA, Zhang Z, Graves M, Khan MA, Baird MC, Russell G, Vijayakumar S. Mourad WF, et al. Among authors: vijayakumar s. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e339-44. doi: 10.1016/j.ijrobp.2011.06.1981. Epub 2011 Oct 20. Int J Radiat Oncol Biol Phys. 2012. PMID: 22019241

10

The impact of body mass index on heterotopic ossification.

Mourad WF, Packianathan S, Shourbaji RA, Zhang Z, Graves M, Khan MA, Baird MC, Russell G, Vijayakumar S. Mourad WF, et al. Among authors: vijayakumar s. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e831-6. doi: 10.1016/j.ijrobp.2011.11.033. Epub 2012 Feb 24. Int J Radiat Oncol Biol Phys. 2012. PMID: 22365623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

710 results

Search Page